string(5) "28358"

hereditary spherocytosis - screening (eosin-5'-maleimide (EMA) staining) Refered Test

Back to main menu

Eurofins Biomnis code

EMA

Synonyms

  • Minkowski - Chauffard disease

Clinic significance

Hereditary spherocytosis, or Minkowski-Chauffard syndrome, is a form of congenital chronic haemolytic anaemia resulting from abnormalities in proteins in the red blood cell membrane.
Flow cytometry by marking with eosin-5'-maleimide (EMA) of transmembrane proteins is n improved replacement for the osmotic fragility test to diagnose hereditary spherocytosis. It sensitivity is > 90% and its specificity is 89¿99% according to studies.

Prenalytics

  • 5 mL
  • EDTA Whole blood
  • Refrigerated

Further information

  • The test must be performed within 72 hours after blood draw
  • ALWAYS attach the specific clinical information form (R39-INTGB :EMA)

Methodology

Flow Cytometry

Turnaround time

30 days


Pathologist(s) in charge
Refered Test
Specialty
Haematology
Contact(s)
Dr Dominique ENGERAND
Dr Isabelle PETIT
Phone(s)
+331 49 59 62 70
+331 49 59 16 72

Caption

Refered TestThe pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.